Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Researcher in Crystal engineering, supramolecular chemistry, and crystallography

Total project amount

82,25 thousand €

Amount paid

82,25 thousand €

Non-refundable funding

82,25 thousand €

Loan funding

0 €

Start date

01.04.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.15700.TENURE.042

Summary

IMS invites applications for a highly motivated and experienced researcher with a Ph.D. in Chemistry or related areas, to produce independent research aligned with the thematic lines of IMS and the research unit CQE. This opportunity entails spearheading the X-ray diffraction facility to support independent research aligned with the MedLife thematic lines, focusing on groundbreaking developments in novel drug forms.The IMS and CQE general mission concerns the strengthening of the contribution of Chemistry to the welfare of Society through high-level research, development, innovation, knowledge transfer, advanced training and teaching activities, building-up scientific and technological skills in both fundamental and oriented/applied research, in science and engineering. The unique structural information provided by the single crystal and powder X-ray diffraction (SCXRD and PXRD, respectively) data is vital to a wealth of scientific fields, serving all the thematic lines within IMS and CQE and over 90% of the groups. The facility also serves diverse external users and has collaboration with companies. The XRD facility within IMS is not just a technological asset but a manifestation of its commitment to advancing Chemistry´s societal contribution. It amplifies the research avenues, catalyzes innovation, facilitates knowledge transfer, empowers advanced training, enriches teaching excellence, and, most importantly, positions IMS, and thus CQE, as contributor to the well-being of society through the transformative power of Chemistry.The researcher hired for this position should be an expert in X-ray diffraction, showcasing competences in SCXRD and PXRD data collection, analysis, and interpretation. Proficiency in crystallography, coupled with extensive experience in managing and operating XRD facilities, is paramount. Additionally, the candidate should exhibit mastery in crystal engineering and supramolecular chemistry, with a proven track record in the area of antimicrobial drug forms targeting multi-resistant microorganisms, substantiated by a robust publication track record.The establishment of effective management of the X-ray diffraction facility within IMS is not merely a choice but a strategic imperative, amplifying the commitment to scientific excellence and societal progress, and addressing UN Sustainable Development Goal 9. The appropriate management of the XRD facilities is fundamental to ensure access to world-class facilities, expertise, and support for the analysis of crystalline materials through PXRD and SCXRD. The selected candidate will play a pivotal role in setting up the instrumentation, maintaining the equipment, managing user access, providing training and support, providing services regarding SCXRD and PXRD, data and interpretation, and ensuring compliance with safety and regulatory guidelines. The mandate extends beyond XRD scientific prowess, demanding autonomy, teamwork, project management finesse, and effective communication skills. These include looking for opportunities to implement advanced instrumentation and different national and international funding mechanisms.Allied with these management skills, the candidate should explore the facility to perform independent research aligned with IMS and CQE interests. Unravelling molecular structures and championing innovative projects within the field of drug discovery is an important asset to advance the frontiers of scientific understanding in global efforts, including against antibiotic resistance within the aims of MEDlife thematic line and aligned with UN Sustainable Development Goal 3. By appointing a researcher for the XRD Facility management with expertise in crystal engineering, and supramolecular chemistry towards new drug forms, significant contributions to the discovery of new therapeutic agents are anticipated, including new approaches to fight antimicrobial resistance societal problems. The prevalence of sustainable synthetic methods, such as mechanochemistry, is expected. The establishment of this position reflects IMS and CQE commitment to staying at the forefront of scientific research and contributing to solutions for urgent public health and environmental challenges.This position will contribute to reinforce the positioning of IMS in XRD and in the myriad of research areas that require XRD as a support technique, advancing the development of new services, and fostering collaboration within the scientific community and with industry. By making simultaneous use of the facility for independent research strongly based on structure elucidation for the development of more effective drug forms, the candidate will further contribute to scientific advances aligned with the research interests of IMS and CQE.Mechanisms are in place to ensure the success of this recruitment, including a thorough selection process and ongoing support for the professional development of the appointed XRD Facility Manager.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

9,2
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

82,25 thousand €

Total amount of the project

Percentage of the amount already paid for implementing projects

, 100 %,

Where was the money spent

By county

1 county financed .

  • Lisboa 82,25 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading